Genmab — November 2020
-
@Pensionisten i have to say, Jan spoke reassuringly
calm and mature about the arbitration on that Jefferies fireside chat; normal part of business in biotech -
dont think this abstract was posted - INTERLEUKIN-8–NEUTRALIZING MONOCLONAL
ANTIBODY BMS-986253 PLUS NIVOLUMAB-- https://jitc.bmj.com/content/jitc/8/Suppl_3/A419.full.pdf -
ADCT-301 in Patients With R/R AML, MDS, or MDS/MPN https://www.clinicaltrials.gov/ct2/show/NCT04639024?term=NCT04639024&draw=2&rank=1 if they are going to start trials with 10 patients, this could take a while....
-
Sælg lidt over 2500 https://www.proinvestor.com/boards/88701/Genmab-retracement#88742
-
a bit more on IL-8 https://twitter.com/follow_5/status/1326351269775118336/photo/1
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind